Recurrent Melanoma Terminated Phase 1 / 2 Trials for RG-4733 (DB11870)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01217411RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerTreatment